Literature DB >> 10599309

Expression of transforming growth factor-alpha and epidermal growth factor receptor in gastrointestinal stromal tumours.

Y C Cai1, Z Jiang, F Vittimberga, X Xu, L Savas, B Woda, M Callery, B Banner.   

Abstract

Activation of epidermal growth factor receptor (EGFR) is associated with cell growth and transformation. Both transforming growth factor-alpha (TGF-alpha) and epidermal growth factor bind to and activate EGFR. We studied the expression of TGF-alpha and two EGFRs (HER-1 and HER-2) in gastrointestinal stromal tumours (GISTs) of the stomach (n = 9) and small intestine (n = 6) using standard immunostaining techniques in paraffin-embedded sections. Most GISTs expressed TGF-alpha, and a few expressed HER-1. All HER-1-positive tumours expressed TGF-alpha. These results suggest that a TGF-alpha/EGFR autocrine loop is present in GIST and that TGF-alpha promotes proliferation of GIST tumour cells through its interaction with HER-1 in at least some GISTs. This is the first description of an autocrine loop in GIST. In contrast, HER-2 is not expressed in any GIST.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10599309     DOI: 10.1007/s004280050407

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  4 in total

1.  A Rare Case of Gastrointestinal Stromal Tumour in Pregnancy Presenting with Upper Gastrointestinal Bleeding.

Authors:  U Parampalli; C Crossland; J Longley; I Morrison; M Sayegh
Journal:  J Gastrointest Cancer       Date:  2012-09

2.  Evaluation of malignancy using Ki-67, p53, EGFR and COX-2 expressions in gastrointestinal stromal tumors.

Authors:  Jing Jiang; Mei-Shan Jin; Jian Suo; Yin-Ping Wang; Liang He; Xue-Yuan Cao
Journal:  World J Gastroenterol       Date:  2012-05-28       Impact factor: 5.742

3.  Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: inhibition by gefitinib ('Iressa', ZD1839).

Authors:  Stephen Hiscox; Liam Morgan; Denise Barrow; Carol Dutkowskil; Alan Wakeling; Robert I Nicholson
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

4.  Novel receptor tyrosine kinase targeted combination therapies for imatinib-resistant gastrointestinal stromal tumors (GIST).

Authors:  Daruka Mahadevan; Noah Theiss; Carla Morales; Amy E Stejskal; Laurence S Cooke; Min Zhu; Drew Kurtzman; Rachel Swart; Evan Ong; Wenqing Qi
Journal:  Oncotarget       Date:  2015-02-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.